Antibody‐enhanced hepatitis E virus nanofiltration during the manufacture of human immunoglobulin is a research paper published in Transfusion (2020). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
This study was funded by the Austrian Research Promotion Agency (FFG) and Baxter AG, Vienna, Austria, now part of the Takeda group of companies.
FWCI
0.57
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords